News

Curatronic Ltd. is pleased to announce the launch of their new website dedicated to PEMF- Pulsed Electromagnetic Field therapy

www.electro-magnetic-therapy.com

August 7, 2012

The new PEMF website features information about the many conditions that can be treated with the Curatron electromagnetic therapy system, including pain, arthritis, osteoporosis and fibromyalgia. Each section provides background information about the specific ailment and how PEMF treatment is beneficial. Applications include pain relief, treatment of various diseases and injuries, and wellness.

On the new website one also finds detailed explanations regarding the technology behind pulsed electromagnetic therapy. All variables are explained in laymanís terms so the clients are able to understand and choose what is important for them.

Curatronic offers 4 different models to choose from according to individual needs. Information is given for all 4 devices, the Curatron XP being the most popular amongst them, excelling in fast pain reduction and providing almost instantaneous pain relief for people suffering from arthritis, fibromyalgia, and back pain.

Further information can be found on the new Curatronic website: www.electro-magnetic-therapy.com

Stroke Rehabilitation System Biomove 5000 approved by the US FDA

The US FDA cleares marketing of the most advanced Stroke Rehabilitation system in the world, manufactured by the Israeli company Curatronic Ltd.

May 1, 2008 --- Curatronic Ltd. announced today that it has obtained U.S. Food and Drug Administration (FDA) marketing approval for their new Biomove 5000 Stroke Rehabilitation system.<

The Biomove 5000 offers very clear audiovisual biofeedback information in combination with muscle stimulation to the stroke survivor, making application not only straight forward in clinical settings but also for use by the stroke survivor at home.

The one knob operated full automatic device detects extremely small electrical EMG signals that persist in spastic muscles after a stroke and uses these tiny signals to initiate electrical stimulation impulses to these muscles, resulting in actual muscle movement. In addition to stroke rehabilitation the new device is also well suited for use with patients suffering from muscle paralysis after Spinal Cord Injury (SCI), Cerebral Palsy (CP) or Traumatic Brain Injury (TBI).

In the more than 700,000 individuals experience a stoke each year. Millions of people suffer from the debilitating effects of stroke. Fifty percent have one-sided paralysis and seek effective treatment for their severe, long-term disabilities.

Ben Philipson, President of Curatronic Ltd. said, "We are very pleased to have now also received FDA marketing approval for the new Biomove 5000 system, in addition to the Biomove 3000 home system already successfully marketed, enabling us to offer this superior and very easy-to-use stroke rehabilitation system to the many stroke survivors in the United States In addition, our CE certification enables us to start marketing of this new device in Europe as well." Lifehealthcare

Stroke Rehabilitation System Biomove 3000 also certified in Australia

Lifehealthcare, the largest distributor of medical equipment in Australia, will sell the Biomove in Australia.

June 8, 2007 --- Curatronic Ltd. announced today that the Australian Government has included the Biomove 3000 as medical device in the Australian Register of Therapeutic Goods.

Lifehealthcare's National Clinical Liaison Manager Jenni Dabelstein said, "It is a great opportunity for our company to be able to offer such an outstanding product to stroke victims in Australia. After extensive trials at several major centers in Brisbane we concluded that the Biomove is an excellent product and we are pleased to offer this device to the many stroke survivors in Australia. Our company makes consistently efforts to bring innovative products to patients, thereby helping to improve the overall standards of stroke treatment in Australia."

Life Healthcare is Australia's leading hospital and rehabilitation supply and distribution company and provides an extensive range of hospital and rehabilitation supplies and equipment across Australia. Recently the company included Lifestyle & Rehab in their Hospital & Rehab Division, consolidating their leading position in the Australian market. The Biomove 3000 system was developed for rehabilitation therapy at home following a stroke. The highly affordable battery-powered device detects extremely small electrical EMG signals that persist in spastic muscles after a stroke and uses these tiny signals to initiate an electrical stimulation impulse to these muscles, resulting in actual muscle movement by the patient.

Millions of people suffer from the debilitating effects of stroke. Fifty percent have some one-sided paralysis and seek effective treatment for their severe, long-term disabilities.

Ben Philipson, CEO of Curatronic Ltd. said, "We are very pleased that our economical, easy-to-use Biomove 3000 system will now also be available in this important market." Bionics Hellas

Biomove 3000 Stroke Rehabilitation Device Now Also Available in Greece

Curatronic has appointed an exclusive distributor for marketing of the Biomove 3000 Stroke Rehabilitation system in Greece.

June 5, 2007 -- Curatronic Ltd. announced today that they have appointed Bionics Hellas as their exclusive distributor for the Biomove 3000 in Greece.

Bionics Hellas' President Alexandros Falkonakis said, "Our company is already well known in Greece for marketing of stroke rehabilitation devices and the addition of the Biomove EMG-triggered muscle stimulator to our program will vastly extend our sales potential, while in addition opening up a new world for the many stroke survivors. We expect that this product will substantially increase our market share and we are pleased to bring this technology to Greece."

Bionics Hellas is the main supplier of stroke rehabilitation products in Greece. Alexandros Falkonakis, the owner of Bionics Hellas, is himself a physical therapist and holds an MSc in Biomedical Engineering. He has worked many years in the fields of orthotics-prosthetics and human movement analysis in the United Kingdom and has extensive experience in Functional Electrical Stimulation (FES).

The Biomove 3000 system was developed for rehabilitation therapy at home following a stroke. The highly affordable battery-powered device detects extremely small electrical EMG signals that persist in spastic muscles after a stroke and uses these tiny signals to initiate an electrical stimulation impulse to these muscles, resulting in actual muscle movement by the patient.

Millions of people suffer from the debilitating effects of stroke. Fifty percent have some one-sided paralysis and seek effective treatment for their severe, long-term disabilities.

Ben Philipson, CEO of Curatronic Ltd., said, "We are consolidating our leading position in the field of stroke rehabilitation and glad to have experienced people to promote this unique technology in Greece as well."

Curatronic Announces a New Audio Version of the Biomove Stroke Rehab Device

Curatronic has introduced an audio prompting system for its Biomove 3000 stroke rehabilitation device, for home use by stroke survivors.

March 28, 2006 -- Many stroke survivors have their eyesight affected and in some cases, eyesight has deteriorated to the stage where it is difficult to see light indicators. The latest audio addition supports a sound prompting system in addition to the light indicator, improving even further the overall friendliness for use of the Biomove device by the stroke survivor in the comfort of their own home.

The Biomove prompts the user to start a new attempt to move the affected muscles and will be rewarded by actual stimulation of these muscles, when such an attempt by the brain for movement is detected. The audio version makes it now possible to use the Biomove system without the need to look at the device during the stroke rehab therapy. "We are extremely excited to offer stroke survivors this additional benefit for the Biomove stroke rehab system making it even easier for them to utilize the device at home without assistance," commented Ben Philipson, CEO of Curatronic Ltd.

The Biomove 3000 system was specially developed for home therapy by the patient following a stroke. After a stroke, control signals from the brain often cannot reach some muscles, typically in the hand or foot. Without these signals, the level of electrical activity in these muscles is too low for them to contract adequately on their own. This causes them to become increasingly weaker.

The Biomove 3000 system, via three electrode patches placed on arm or leg, detects and amplifies even the slightest signals still being generated in the hand and foot muscles. Then, using an advanced form of biofeedback combined with electrical muscle stimulation the Biomove re-teaches the muscles to contract on their own. FDA 510(k) approval allows the Biomove 3000 to be marketed in the United States, where over 700,000 individuals experience a stroke each year. Millions of people suffer from the debilitating effects of stroke. Fifty percent have some one-sided paralysis and seek effective treatment for their severe, long-term disabilities.

In addition Curatronic has been awarded CE certification qualifying the Biomove stroke rehab system for sale throughout the 25-nation European Union ("EU") and four-nation European Free Trade Association ("EFTA").


Booth International Stroke Conference

High Marks for the Biomove 3000 Stroke Rehab Device during the International Stroke Conference

High marks were given by stroke rehabilitation experts for the Biomove Stroke Rehab device for home use, during the Stroke Conference organized by the American Stroke Association, which took place from February 16-18 in Kissimmee, Florida.

March 7, 2006 -- Extensive attention was drawn by the action to give away 20 Biomove Stroke Rehab systems to stroke survivors in the US by the manufacturer Curatronic Ltd. in cooperation with their national distributor Amjo Corp.

Attending physicians who tested the device on themselves unilaterally expressed their satisfaction about the straight forward application of the Biomove and ease of use for the stroke survivor at home. One of the attending neurologists, herself a stroke survivor, succeeded for the first time after 14 years in raising her hand with the help of the Biomove.

Many stroke rehab specialists decided to prescribe this new device to selected patients to enable them to participate in the free Biomove give away action. Further details on the drawing date and the contest details can be found at the www.MyStroke.com website.

Ben Philipson of Curatronic Ltd. said, "We are very encouraged that the Biomove stroke rehab system has enthusiastically been received by the stroke rehab experts during this important event, in addition to the many Biomove users around the world. Many stroke survivors have given us very positive feedback about their progress with this economical, easy- to-use system".

Free Biomove 3000 Stroke Rehab Devices for Stroke Survivors

Free Biomove 3000 Stroke Rehab Devices for Stroke Survivors

Curatronic Ltd and Amjo Corp will GIVE AWAY 20 (TWENTY) Biomove Stroke Therapy systems.

January 24, 2006 - Twenty Biomove stroke rehab systems will be supplied free of charge through a drawing to stroke survivors across the USA. Contest entrants must be stroke survivors and live in the USA.

Ben Philipson of Curatronic Ltd. said, "We are very pleased that the Biomove stroke rehab system has been received so enthusiastic by patients and health care professionals within such a short time. Many stroke survivors have given us already very encouraging feedback about their progress with this economical, easy- to-use system".

The Biomove 3000 system was specially developed for home therapy by the patient following a stroke. After a stroke, control signals from the brain often cannot reach some muscles, typically in the hand or foot. Without these signals, the level of electrical activity in these muscles is too low for them to contract adequately on their own. This causes them to become increasingly weaker.

"I have worked with many patients with CVA over the years retraining the functions of the upper reach and grasp and lower extremity stance and gait. I introduce this equipment to my students and hope that they will have it available to use in their clinical work after graduation. The best system I have seen for doing this so far, in terms of ease, adaptability, and simplicity of use, both for the therapist and the patient, is the Biomove 3000," says Prof. Jim Stephens at Temple University. "All you need is a tiny bit of movement - even a finger or toe wiggling - to be a candidate for Biomove therapy," says Prof. Leonard Elbaum at Florida International University.

New HOME Stroke Rehabilitation device Biomove 3000 receives CE certification in addition to recently obtained US FDA approval

European CE certification, in addition to US FDA approval, for marketing of the highly affordable and easy to use Home Stroke Therapy device Biomove 3000 manufactured by the Israeli company Curatronic Ltd.

August 31, 2005 --- Curatronic Ltd. announced today that it has obtained CE certification for the Biomove 3000 Stroke Rehabilitation system, which has been received extremely well by health professionals and patients throughout the US.

The Biomove 3000 system was specifically developed for home therapy following a stroke. The highly affordable battery-powered device detects extremely small electrical EMG signals that persist in paralyzed muscles after a stroke and uses these tiny signals to initiate an electrical stimulation impulse to the muscles, resulting in actual muscle movement by the patient.

Millions of people suffer from the debilitating effects of stroke. Fifty percent have some one-sided paralysis and seek effective treatment for their severe, long-term disabilities. FDA 510(k) approval allows Biomove 3000 to be marketed in the United States, where over 700,000 individuals experience a stroke each year. CE certification allows marketing throughout Europe where over one million new stroke survivors are added yearly.

Ben Philipson, President of Curatronic Ltd. said, "We are delighted to have received CE certification in addition to US FDA approval for the Biomove 3000 system, which enables us to reach the many stroke victims with our economical, easy-to-use system.

Amjo Corp Announces the Introduction of a New Stroke Therapy Device, the First EMG Triggered NMES Device Targeted at Stroke Sufferers for Home Use

Stroke Sufferers now have one more option: EMG triggered NMES at home is now both affordable and possible. The system is able to detect extremely small electrical EMG signals that persist in paralyzed muscles after a stroke. These tiny signals are used to initiate an electrical stimulation impulse to the same muscles, resulting in actual muscle movement!

March 26, 2005 -- The Biomove 3000 system was specifically developed for home therapy following a stroke. The highly affordable battery-powered device detects extremely small electrical EMG signals that persist in paralyzed muscles after a stroke and uses these tiny signals to initiate an electrical stimulation impulse to the muscles, resulting in actual muscle movement by the patient.

FDA 510(k) approval allows Biomove 3000 to be marketed in the United States, where over 700,000 individuals experience a stroke each year. Millions of people suffer from the debilitating effects of stroke. Fifty percent have some one-sided paralysis and seek effective treatment for their severe, long-term disabilities.

Chris Cane of Amjo Corp said, "We are delighted that Curatronic Ltd (the developer of the Biomove 3000) has received FDA approval for the Biomove 3000 system, which enables us to reach the many stroke victims in the US market with this economical, easy-to-use system. Jim Stephens PT, PhD, CFP, Physical Therapy Department at Temple University says: "As a physical therapist, I have worked with many patients with CVA over the years retraining the functions of the upper reach and grasp and lower extremity stance and gait. I found that some patients are able to use EMG feedback very well. This effectiveness was enhanced by addition of electrical stimulation of the contracting muscle to supplement a movement that was already in progress. My clinical experience suggests, as research is beginning to show, that a system of EMG triggered electrical stimulation is an effective means of restoring function. I introduce this equipment to my students and hope that they will have it available to use in their clinical work after graduation. The best system I have seen for doing this so far, in terms of ease, adaptability, and simplicity of use, both for the therapist and the patient, is the Biomove 3000."

US FDA Approves Marketing of Biomove 3000 for Stroke Rehabilitation. The Highly Affordable Home Therapy System Enters U.S Market

US FDA approves marketing of the highly affordable and easy to use Home Stroke Therapy device Biomove 3000 manufactured by Curatronic Ltd.

March 15, 2005 -- Hashmonaim, Israel --- Curatronic Ltd. announced today that it has obtained U.S. Food and Drug Administration (FDA) marketing approval for the Biomove 3000 Stroke Rehabilitation system.

The Biomove 3000 system was specifically developed for home therapy following a stroke. The highly affordable battery-powered device detects extremely small electrical EMG signals that persist in paralyzed muscles after a stroke and uses these tiny signals to initiate an electrical stimulation impulse to the muscles, resulting in actual muscle movement by the patient.

FDA 510(k) approval allows Biomove 3000 to be marketed in the United States, where over 700,000 individuals experience a stroke each year. Millions of people suffer from the debilitating effects of stroke. Fifty percent have some one-sided paralysis and seek effective treatment for their severe, long-term disabilities.

Ben Philipson, President of Curatronic Ltd. said, "We are delighted to have received FDA approval for the Biomove 3000 system, which enables us to reach the many stroke victims in the US market with our economical, easy-to-use system.